Provided by Tiger Fintech (Singapore) Pte. Ltd.

PagerDuty, Inc.

16.44
-0.1400-0.84%
Post-market: 16.40-0.0400-0.24%19:59 EDT
Volume:2.34M
Turnover:38.28M
Market Cap:1.53B
PE:-104.34
High:16.68
Open:16.65
Low:16.13
Close:16.58
52wk High:21.98
52wk Low:13.70
Shares:93.25M
Float Shares:82.10M
Volume Ratio:0.97
T/O Rate:2.84%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.1576
EPS(LYR):-0.5920
ROE:-6.86%
ROA:-1.99%
PB:8.48
PE(LYR):-27.77

Loading ...

HENLIUS (02696): FDA Approves Clinical Trial Application for Pembrolizumab Biosimilar HLX17 in Patients with Multiple Resected Solid Tumors

Stock News
·
Sep 08

Palisade Bio Receives Health Canada Clearance for Phase 1b Trial of PALI-2108 in Fibrostenotic Crohn’s Disease (FSCD)

GlobeNewswire
·
Sep 05

Hong Kong Stock Alert | ABBISKO-B (02256) Opens High Over 6% Hitting Record High, Company Benefits from Multiple Positive Catalysts as Oral PD-L1 Combination with Glecirasib Receives Phase II Clinical Approval

Stock News
·
Sep 05

PagerDuty's H2 Outlook Buoyed by Pricing Moves Despite User Reductions, RBC Says

MT Newswires Live
·
Sep 05

BUZZ-U.S. STOCKS ON THE MOVE- Gap, Aquestive Therapeutics, Lumentum

Reuters
·
Sep 04

PagerDuty Shares Climb 4.9%

THOMSON REUTERS
·
Sep 04

Stock Track | PagerDuty Soars 5% Despite Lowered Annual Forecast and Mixed Analyst Reactions

Stock Track
·
Sep 04

TRANSTHERA-B (02617): Phase II Clinical Trial of Tinengotinib Combined with AKESO's Kantani® (Cadonilimab, PD-1/CTLA-4) / Ivonesca® (Ivonescimab, PD-1/VEGF) Completes First Patient Dosing

Stock News
·
Sep 04

BUZZ-PagerDuty fall after annual forecasts trimmed

Reuters
·
Sep 04

RBC Capital Adjusts PagerDuty Price Target to $18 From $20, Maintains Outperform Rating

MT Newswires Live
·
Sep 04

Clene Presents Preclinical Data Supporting CNM-Au8® for the Treatment of Parkinson’s Disease

GlobeNewswire
·
Sep 04

PagerDuty Is Maintained at Buy by Canaccord Genuity

Dow Jones
·
Sep 04

Gain Therapeutics Receives Australian Approval of Phase 1b Dosing Extension and Reports Positive Independent Data Monitoring Committee Recommendation

GlobeNewswire
·
Sep 04

PagerDuty Shares Fall 3% Premarket After Q2 Results

THOMSON REUTERS
·
Sep 04

U.S. RESEARCH ROUNDUP-Alphabet, Copart, Leidos

Reuters
·
Sep 04

BRIEF-Pagerduty Appoints Todd Mcnabb As Chief Revenue Officer

Reuters
·
Sep 04

BRIEF-PagerDuty's Board Approved $200 Million Share Repurchase Program

Reuters
·
Sep 04

PagerDuty Inc reports results for the quarter ended July 31 - Earnings Summary

Reuters
·
Sep 04

PagerDuty Q2 Adjusted EPS USD 0.3

THOMSON REUTERS
·
Sep 04

PagerDuty Q2 Revenue USD 123 Million

THOMSON REUTERS
·
Sep 04